312 related articles for article (PubMed ID: 38179655)
21. Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review).
Naser R; Fakhoury I; El-Fouani A; Abi-Habib R; El-Sibai M
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579669
[TBL] [Abstract][Full Text] [Related]
22. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
23. Mechanoimmunology in the solid tumor microenvironment.
Golo M; Newman PLH; Kempe D; Biro M
Biochem Soc Trans; 2024 Jun; 52(3):1489-1502. PubMed ID: 38856041
[TBL] [Abstract][Full Text] [Related]
24. Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies.
Belli C; Antonarelli G; Repetto M; Boscolo Bielo L; Crimini E; Curigliano G
Cancers (Basel); 2022 Sep; 14(17):. PubMed ID: 36077813
[TBL] [Abstract][Full Text] [Related]
25. Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy.
Chen Q; Guo X; Ma W
Oncol Res; 2023; 32(1):49-60. PubMed ID: 38188674
[TBL] [Abstract][Full Text] [Related]
26. The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications.
Ilie MD; Vasiljevic A; Raverot G; Bertolino P
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31640258
[TBL] [Abstract][Full Text] [Related]
27. Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals.
Malla RR; Deepak K; Merchant N; Dasari VR
Phytomedicine; 2020 Apr; 70():153227. PubMed ID: 32339885
[TBL] [Abstract][Full Text] [Related]
28. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
Deepak KGK; Vempati R; Nagaraju GP; Dasari VR; S N; Rao DN; Malla RR
Pharmacol Res; 2020 Mar; 153():104683. PubMed ID: 32050092
[TBL] [Abstract][Full Text] [Related]
29. Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
Xu Y; Xiong J; Sun X; Gao H
Acta Pharm Sin B; 2022 Dec; 12(12):4327-4347. PubMed ID: 36561994
[TBL] [Abstract][Full Text] [Related]
30. Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions.
Bandi DSR; Sarvesh S; Farran B; Nagaraju GP; El-Rayes BF
Cytokine Growth Factor Rev; 2023; 71-72():26-39. PubMed ID: 37407355
[TBL] [Abstract][Full Text] [Related]
31. Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy.
Heidegger I; Pircher A; Pichler R
Front Oncol; 2019; 9():490. PubMed ID: 31259150
[TBL] [Abstract][Full Text] [Related]
32. Applications of Single-Cell Omics to Dissect Tumor Microenvironment.
Guo T; Li W; Cai X
Front Genet; 2020; 11():548719. PubMed ID: 33329692
[TBL] [Abstract][Full Text] [Related]
33. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine.
van der Heide CD; Dalm SU
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4616-4641. PubMed ID: 35788730
[TBL] [Abstract][Full Text] [Related]
34. Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment.
Hameed S; Bhattarai P; Dai Z
Sci China Life Sci; 2018 Apr; 61(4):380-391. PubMed ID: 29607461
[TBL] [Abstract][Full Text] [Related]
35. Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.
Li D; Xu W; Chang Y; Xiao Y; He Y; Ren S
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(6):956-973. PubMed ID: 37294106
[TBL] [Abstract][Full Text] [Related]
36. 3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment.
Zhang Z; Chen X; Gao S; Fang X; Ren S
Cell Oncol (Dordr); 2024 Mar; ():. PubMed ID: 38520648
[TBL] [Abstract][Full Text] [Related]
37. Targeting the prostate tumor microenvironment by plant-derived natural products.
Wu J; Ji H; Li T; Guo H; Xu H; Zhu J; Tian J; Gao M; Wang X; Zhang A
Cell Signal; 2024 Mar; 115():111011. PubMed ID: 38104704
[TBL] [Abstract][Full Text] [Related]
38. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
39. Microphysiological systems as models for immunologically 'cold' tumors.
Gaebler D; Hachey SJ; Hughes CCW
Front Cell Dev Biol; 2024; 12():1389012. PubMed ID: 38711620
[TBL] [Abstract][Full Text] [Related]
40. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
